James R. Neal - 19 Jul 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ James Neal by Neda Sharifi, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
19 Jul 2022
Net transactions value
$0
Form type
4
Filing time
21 Jul 2022, 16:46:32 UTC
Previous filing
18 Jul 2022
Next filing
03 Nov 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Award $0 +17,797 $0.000000 17,797 19 Jul 2022 Common Stock 17,797 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The restricted stock vest on the earlier of one year from the grant date or the next annual meeting of stockholders.